Deploying Minimally Invasive Transplant Tests in Kidney Disease Treatment
Tina Liedtky
Minimally invasive testing options can be less risky and less expensive compared to traditional, invasive biopsies
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers